• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经股动脉经导管主动脉瓣植入术后的早期活动:MobiTAVI试验结果

Early mobilisation after transfemoral transcatheter aortic valve implantation: results of the MobiTAVI trial.

作者信息

Vendrik J, Vlastra W, van Mourik M S, Delewi R, Beijk M A, Lemkes J, Wykrzykowska J J, de Winter R J, Henriques J S, Piek J J, Vis M M, Koch K T, Baan J

机构信息

Heart Centre, Amsterdam University Medical Centres (location AMC), Amsterdam, The Netherlands.

Heart Centre, Amsterdam University Medical Centres (location VUMC), Amsterdam, The Netherlands.

出版信息

Neth Heart J. 2020 May;28(5):240-248. doi: 10.1007/s12471-020-01374-5.

DOI:10.1007/s12471-020-01374-5
PMID:32112292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7190768/
Abstract

BACKGROUND

Immobilisation of patients after transfemoral transcatheter aortic valve implantation (TF-TAVI) is the standard of care, mostly to prevent vascular complications. However, immobilisation may increase post-operative complications such as delirium and infections. In this trial, we determine whether it is feasible and safe to implement early ambulation after TF-TAVI.

METHODS

We prospectively included TF-TAVI patients from 2016 to 2018. Patients were assessed for eligibility using our strict safety protocol and were allocated (based on the time at which the procedure ended) to the EARLY or REGULAR group.

RESULTS

A total of 150 patients (49%) were deemed eligible for early mobilisation, of which 73 were allocated to the EARLY group and 77 to the REGULAR group. The overall population had a mean age of 80 years, 48% were male with a Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) score of 3.8 ± 1.8. Time to mobilisation was 4 h 49 min ± 31 min in the EARLY group versus 20 h 7 min ± 3 h 6 min in the REGULAR group (p < 0.0001). There were no differences regarding the primary endpoint. No major vascular complications occurred and a similar incidence of minor vascular complications was seen in both groups (4/73 [5.5%] vs 6/77 [7.8%], p = 0.570). The incidence of the combined secondary endpoint was lower in the EARLY group (p = 0.034), with a numerically lower incidence for all individual outcomes (delirium, infections, pain and unplanned urinary catheter use).

CONCLUSION

Early mobilisation (ambulation 4-6 h post-procedure) of TF-TAVI patients is feasible and safe. Early ambulation decreases the combined incidence of delirium, infections, pain and unplanned urinary catheter use, and its adoption into contemporary TAVI practice may therefore be beneficial.

摘要

背景

经股动脉经导管主动脉瓣植入术(TF-TAVI)后让患者制动是标准治疗措施,主要是为了预防血管并发症。然而,制动可能会增加术后并发症,如谵妄和感染。在本试验中,我们确定TF-TAVI术后早期活动是否可行且安全。

方法

我们前瞻性纳入了2016年至2018年的TF-TAVI患者。使用我们严格的安全方案评估患者的 eligibility,根据手术结束时间将患者分配到早期组或常规组。

结果

共有150名患者(49%)被认为适合早期活动,其中73名被分配到早期组,77名被分配到常规组。总体人群的平均年龄为80岁,48%为男性,胸外科医师协会预测死亡率(STS-PROM)评分为3.8±1.8。早期组的活动时间为4小时49分钟±31分钟,而常规组为20小时7分钟±3小时6分钟(p<0.0001)。关于主要终点没有差异。两组均未发生重大血管并发症,轻微血管并发症的发生率相似(4/73[5.5%]对6/77[7.8%],p=0.570)。早期组联合次要终点的发生率较低(p=0.034),所有个体结局(谵妄、感染、疼痛和非计划使用导尿管)的发生率在数值上也较低。

结论

TF-TAVI患者早期活动(术后4-6小时活动)是可行且安全的。早期活动可降低谵妄、感染、疼痛和非计划使用导尿管的联合发生率,因此将其纳入当代TAVI实践可能有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf0/7190768/a2b5f9969695/12471_2020_1374_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf0/7190768/582eaaaf5909/12471_2020_1374_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf0/7190768/a2b5f9969695/12471_2020_1374_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf0/7190768/582eaaaf5909/12471_2020_1374_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf0/7190768/a2b5f9969695/12471_2020_1374_Fig2_HTML.jpg

相似文献

1
Early mobilisation after transfemoral transcatheter aortic valve implantation: results of the MobiTAVI trial.经股动脉经导管主动脉瓣植入术后的早期活动:MobiTAVI试验结果
Neth Heart J. 2020 May;28(5):240-248. doi: 10.1007/s12471-020-01374-5.
2
Ongoing transcatheter aortic valve implantation (TAVI) practice amidst a global COVID-19 crisis: nurse-led analgesia for transfemoral TAVI.全球新冠疫情危机下经导管主动脉瓣植入术(TAVI)的持续开展:经股动脉TAVI的护士主导镇痛
Neth Heart J. 2020 Jul;28(7-8):384-386. doi: 10.1007/s12471-020-01472-4.
3
Comparison of early and midterm outcomes after transsubclavian/axillary versus transfemoral, transapical, or transaortic transcatheter aortic valve implantation.经锁骨下动脉/腋窝与经股动脉、经心尖或经主动脉途径行经导管主动脉瓣植入术的早期和中期结果比较。
Heart Lung. 2019 Nov-Dec;48(6):519-529. doi: 10.1016/j.hrtlng.2019.04.002. Epub 2019 May 7.
4
Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths.经股动脉、经心尖和经导管主动脉瓣植入术及外科主动脉瓣置换术:早期和中期死亡的直接和校正间接比较的荟萃分析
Interact Cardiovasc Thorac Surg. 2017 Sep 1;25(3):484-492. doi: 10.1093/icvts/ivx150.
5
Transradial Secondary Access to Guide Valve Implantation and Manage Peripheral Vascular Complications During Transcatheter Aortic Valve Implantation.经桡动脉二次入路用于经导管主动脉瓣植入术中引导瓣膜植入及处理外周血管并发症
Heart Lung Circ. 2019 Apr;28(4):637-646. doi: 10.1016/j.hlc.2018.02.025. Epub 2018 Mar 10.
6
A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.一项关于使用爱德华兹瓣膜进行经股动脉与经心尖经导管主动脉瓣植入术治疗严重主动脉瓣狭窄患者的死亡率及主要不良心血管和脑血管事件的荟萃分析。
Am J Cardiol. 2014 Dec 15;114(12):1882-90. doi: 10.1016/j.amjcard.2014.09.029. Epub 2014 Sep 28.
7
Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.经股动脉导管主动脉瓣植入术后早期出院的可行性与安全性——FAST-TAVI注册研究的原理与设计
BMC Cardiovasc Disord. 2017 Oct 10;17(1):259. doi: 10.1186/s12872-017-0693-0.
8
Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.经股动脉导管主动脉瓣植入术后血管并发症的可预测性及结局
J Heart Valve Dis. 2016 Mar;25(2):173-181.
9
Surgical cutdown versus percutaneous access in transfemoral transcatheter aortic valve implantation: Insights from the Brazilian TAVI registry.经股动脉经导管主动脉瓣植入术中手术切开与经皮穿刺入路的比较:来自巴西经导管主动脉瓣植入术登记处的见解
Catheter Cardiovasc Interv. 2015 Sep;86(3):501-5. doi: 10.1002/ccd.25820. Epub 2015 Feb 11.
10
Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.经导管主动脉瓣植入术(TAVI)的极简方法:开放血管法与完全经皮法
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1;40(2):5-14. doi: 10.2478/prilozi-2019-0009.

引用本文的文献

1
Management of conduction disturbances after TAVI: the last step towards early discharge.经导管主动脉瓣植入术后传导障碍的管理:迈向早期出院的最后一步。
J Geriatr Cardiol. 2025 May 28;22(5):534-546. doi: 10.26599/1671-5411.2025.05.004.
2
Randomized Trial of Shortened Supine Bedrest Following Transfemoral Transcatheter Aortic Valve Replacement.经股动脉经导管主动脉瓣置换术后缩短仰卧位卧床休息的随机试验
J Soc Cardiovasc Angiogr Interv. 2025 Mar 18;4(3Part A):102564. doi: 10.1016/j.jscai.2025.102564. eCollection 2025 Mar.
3
Evaluation of systemic inflammatory response following transcatheter aortic valve replacement: a pathway to rational antibiotic use.

本文引用的文献

1
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
2
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.经导管主动脉瓣置换术治疗低危患者的自膨式瓣膜。
N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16.
3
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.
经导管主动脉瓣置换术后全身炎症反应的评估:合理使用抗生素的途径。
Infection. 2025 Feb 7. doi: 10.1007/s15010-025-02485-0.
4
A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.经导管主动脉瓣植入术的简化途径:BENCHMARK 研究。
Eur Heart J. 2024 Jun 1;45(21):1904-1916. doi: 10.1093/eurheartj/ehae147.
5
Does Comprehensive Geriatric Assessment Reduce the Incidence of Postoperative Delirium? A Quasi-experimental Study in Older Adults Undergoing Transcatheter Aortic Valve Implantation.综合老年评估能否降低术后谵妄的发生率?一项针对接受经导管主动脉瓣植入术的老年人的准实验研究。
Clin Interv Aging. 2024 Feb 28;19:347-355. doi: 10.2147/CIA.S448167. eCollection 2024.
6
Contemporary European practice in transcatheter aortic valve implantation: results from the 2022 European TAVI Pathway Registry.当代欧洲经导管主动脉瓣植入术的实践:来自2022年欧洲经导管主动脉瓣植入术路径注册研究的结果
Front Cardiovasc Med. 2023 Aug 14;10:1227217. doi: 10.3389/fcvm.2023.1227217. eCollection 2023.
7
Transfemoral transcatheter aortic valve implantation: towards local anaesthesia for everyone?经股动脉导管主动脉瓣植入术:能否实现人人都采用局部麻醉?
Neth Heart J. 2022 Nov;30(11):499-502. doi: 10.1007/s12471-022-01728-1. Epub 2022 Oct 24.
8
MANTA closure device shows promise in transfemoral transcatheter aortic valve replacement.MANTA封堵装置在经股动脉导管主动脉瓣置换术中显示出前景。
Neth Heart J. 2020 Dec;28(12):637-638. doi: 10.1007/s12471-020-01511-0. Epub 2020 Oct 28.
9
The history of transcatheter aortic valve implantation: The role and contribution of an early believer and adopter, the Netherlands.经导管主动脉瓣植入术的历史:早期支持者与采用者荷兰的角色及贡献。
Neth Heart J. 2020 Aug;28(Suppl 1):128-135. doi: 10.1007/s12471-020-01468-0.
温哥华 3M(多学科、多模式但简约)临床路径促进低、中、高容量经股动脉经导管主动脉瓣置换中心安全次日出院:3M TAVR 研究。
JACC Cardiovasc Interv. 2019 Mar 11;12(5):459-469. doi: 10.1016/j.jcin.2018.12.020.
4
Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide.经导管主动脉瓣置换术后应用 MANTA 与 ProGlide 血管闭合装置的倾向性匹配比较。
EuroIntervention. 2019 Feb 8;14(15):e1558-e1565. doi: 10.4244/EIJ-D-18-00769.
5
The Sooner the Better?: The Doctor Knows Best.
JACC Cardiovasc Interv. 2018 Sep 10;11(17):1772-1774. doi: 10.1016/j.jcin.2018.06.057.
6
Early Versus Standard Discharge After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.经导管主动脉瓣置换术后早期与标准出院的比较:系统评价和荟萃分析。
JACC Cardiovasc Interv. 2018 Sep 10;11(17):1759-1771. doi: 10.1016/j.jcin.2018.04.042.
7
Infections after transcatheter versus surgical aortic valve replacement: mid-term results of 200 consecutive patients.经导管主动脉瓣置换术与外科主动脉瓣置换术后感染情况:200例连续患者的中期结果
J Thorac Dis. 2018 Jul;10(7):4342-4352. doi: 10.21037/jtd.2018.06.54.
8
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis.经导管主动脉瓣置换术治疗有症状的低危重度主动脉瓣狭窄患者。
J Am Coll Cardiol. 2018 Oct 30;72(18):2095-2105. doi: 10.1016/j.jacc.2018.08.1033. Epub 2018 Aug 28.
9
MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.Manta 与 ProGlide 血管闭合装置在经股动脉经导管主动脉瓣植入术中的比较。
Int J Cardiol. 2018 Jul 15;263:29-31. doi: 10.1016/j.ijcard.2018.04.065. Epub 2018 Apr 14.
10
Optimization and simplification of transcatheter aortic valve implantation therapy.经导管主动脉瓣植入治疗的优化与简化
Expert Rev Cardiovasc Ther. 2018 Apr;16(4):287-296. doi: 10.1080/14779072.2018.1449644. Epub 2018 Mar 9.